A simple, fast, and reliable two step procedure for the detection of non-cx-thalassaemias in mass screening programmes is presented.
Introduction
The treatment and retrospective prevention of Cooley's anaemia have severe limitations. Prospective prevention is, at least in principle, the only totally effective way to cope successfully with this disease. Any global programme for prospective prevention requires, as a preliminary step, the reliable identification of young people with thalassaemia (which must then be followed by genetic counselling and antenatal diagnosis). Unfortunately, in most affected areas no mass screenings have been performed despite the fact that several theoretically effective strategies are available.
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We describe a simple, fast, reliable, and low cost mass screening procedure that we have developed over the past 40 years.
I Methods
Over seven years' screening for thalassaemias in secondary schools in Latium we took a total of 289 763 blood samples. All school students were systematically examined in their last year of compulsory education (age group 13-14).
STEP 1
Every blood specimen underwent (a) a study of red cell morphology, and (b) a test of osmotic fragility.
Red cell morphology was examined on a freshly made, unstained blood film, smeared in such a way that it included a monolayer of well spread and distinct erythrocytes; this made it possible to detect anisocytosis, poikilocytosis, red cell fragments, and target cells, as well as hypochromia and an opacity that contrasts with the refractile appearance of normal erythrocytes. densitometer with manual scanning was used to measure the density of haemoglobin A2. When electrophoresis showed the presence of haemoglobin F, this was quantitated by the Betke method.3 studies) to distinguish between oa-thalassaemia and iron deficiency anaemia ( figure) . Table II summarises the results of this method over seven years in all schools of our region.
Results and comment Table I shows that the two tests of step 1 detected virtually all subjects with thalassaemia. There must be liberal admission to 
Discussion
The procedure described appears to fulfil all criteria required for mass screening for thalassaemia, and it may be applied even with few laboratory facilities and trained personnel. The two tests of step 1 are so simple and rapid that a team of three operators can process 400-500 samples a day under field conditions. A one month course is sufficient to learn how to carry out these two tests and to interpret results.
The only cases that remain undetected by this method are those with an isolated high haemoglobin A"7 and the so called "silent" thalassaemias, which can be identified only through biosynthetic studies. In Latium about 0-3 " of the non-a thalassaemias (13 out of the 3000 cases identified among about 60 000 subjects) had an isolated high haemoglobin A2. The "silent" thalassaemias are probably even more rare: none of the mothers of about 500 patients with Cooley's anaemia examined by us in the past 30 years had this type of 5-thalassaemia.
Apart from the salaries of the necessary personnel, the cost of step 1 is minimal. The unit cost is about J1 10, so the total spent on 42 000 tests was £46 200. The step 2 tests are more expensive (unit cost of about C3 50), but the advantage of our approach is that they were performed on a selected subsample only. Thus in our study 8000 samples were studied for £28 000. The all inclusive cost per year of our screening (about 50 000 students) was about C74 000. If, as a result of our screening, even just one birth of a patient with thalassaemia major was prevented (out of the eight or nine expected to be born in Latium every year), the cost incurred would be fully recovered.
The potential of this procedure to prevent the birth of patients with Cooley's anaemia is not appreciably lowered by its failure to detect the cases of isolated high haemoglobin A2 and the silent rb-thalassaemias if every carrier of 3-thalassaemia allows his or her partner to undergo full investigation.
Other screening strategies have been proposed. Discriminant analyses based on red cell indices8 " are quite expensive and fail to detect some 20' of thalassaemias. Kattamis et all" have carried out a trial of screening in Lesbos using a one tube osmotic fragility test alone at a saline concentration of 3-6 g/l: they identified 71 out of 72 cases of 3-thalassaemia. In our population the failure rate of the osmotic fragility test alone is much higher-about 8". In Sardinia, where the incidence of thalassaemia is extremely high (20-25"i,), a screening procedure in which red cell indices, electrophoresis of haemoglobin, and microchromatographic assay of haemoglobin A. are carried out on every sample has been adopted."l Clearly the approach guarantees the identification of all cases of r-thalassaemia but it is necessarily slow and very expensive (about £4-30 per blood specimen).
The best choice among various screening strategies depends on several variables, such as the incidence of thalassaemia and of other haemoglobinopathies, the frequency of iron deficiency anaemia, the ratio between the size of the area and the availability of laboratory facilities, and economic resources. Thus we do
Step 1 (100%) incidence of x-thalassaemia and 5-thalassaemia, of haemoglobin E, and of iron deficiency anaemias. For areas with intermediate incidence, however, such as most of Italy and probably most of southern Europe, the approach we have described would seem to provide a high level of reliability with a low cost.
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Influence of Doppler ultrasound on fetal activity A J MURRILLS, P BARRINGTON, P D HARRIS, T WHEELER Abstract A randomised and double blind study of 100 subjects and 50 controls was performed to confirm or refute a report from Cardiff in 1975 that continuous Doppler ultrasound, as used in fetal heart rate monitoring, increases fetal movement by over 90%. The results showed such an effect to be most unlikely (power >0-99). A total of 150 pregnant mothers recorded fetal movements for 30 minutes while connected to a specially modified cardiotocograph, the ultrasound being switched on at random for either the first or second 15 minutes in 100 of the patients. The mean difference in 15 minute movement count, with and without ultrasound, among the 100 patients was 0-2 of a movement (SD 12-7; p >0 6 Introduction In 1975 David et al reported that exposure of the fetus to Doppler ultrasound caused an increase in fetal activity of over 90%.1 Four years later, however, two other studies were published,2 3 and neither of these was confirmatory. Unfortunately none of these studies was performed double blind and each included only a small number of subjects; there were also appreciable differences between them in experimental design.
Because of the important implications of the results of David et al we decided that a large, randomised, controlled, and double blind experiment should be carried out, but whose design should deliberately be kept sufficiently similar to that of David et al to permit a meaningful comparison of results. In order to optimise the design of the main study and provide preliminary information on fetal movement we also mounted a pilot study.
Pilot study
Fetal movements felt by 50 mothers or seen by an observer watching the abdomen were recorded separately on a two channel chart recorder using hand held push buttons. No ultrasound equipment was
